Literature DB >> 11359913

B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.

S Xu1, K P Lam.   

Abstract

B-cell maturation protein (BCMA) is a member of the tumor necrosis factor (TNF) receptor family and is expressed in B lymphocytes. BCMA binds two TNF family members, BAFF and APRIL, that stimulate cellular proliferation. BAFF in particular has been shown to influence B-cell survival and activation, and transgenic mice overexpressing BAFF have a lupus-like autoimmune disorder. We have inactivated BCMA in the mouse germ line. BCMA(-/-) mice have normal B-cell development, and the life span of mutant B lymphocytes is comparable to that of wild-type B cells. The humoral immune responses of BCMA(-/-) mice to T-cell-independent antigens as well as high and low doses of T-cell-dependent antigens are also intact. In addition, mutant mice have normal splenic architecture, and germinal centers are formed during an ongoing immune response. These data suggest a functional redundancy of BCMA in B-cell physiology that is probably due to the presence of TACI, another TNF receptor family member that is expressed on B cells and that can also bind BAFF and APRIL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359913      PMCID: PMC87068          DOI: 10.1128/MCB.21.12.4067-4074.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

Authors:  G U von Bülow; R J Bram
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

Review 2.  Co-stimulation in T cell responses.

Authors:  C A Chambers; J P Allison
Journal:  Curr Opin Immunol       Date:  1997-06       Impact factor: 7.486

3.  B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1.

Authors:  H B Shu; H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed.

Authors:  Y Laabi; M P Gras; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

5.  TALL-1 is a novel member of the TNF family that is down-regulated by mitogens.

Authors:  H B Shu; W H Hu; H Johnson
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

Review 6.  Tumor necrosis factor receptor family members in the immune system.

Authors:  L A Gravestein; J Borst
Journal:  Semin Immunol       Date:  1998-12       Impact factor: 11.130

7.  The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily.

Authors:  C Madry; Y Laabi; I Callebaut; J Roussel; A Hatzoglou; M Le Coniat; J P Mornon; R Berger; A Tsapis
Journal:  Int Immunol       Date:  1998-11       Impact factor: 4.823

8.  BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes.

Authors:  M P Gras; Y Laâbi; G Linares-Cruz; M O Blondel; J P Rigaut; J C Brouet; G Leca; R Haguenauer-Tsapis; A Tsapis
Journal:  Int Immunol       Date:  1995-07       Impact factor: 4.823

9.  A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

Authors:  Y Laâbi; M P Gras; F Carbonnel; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.

Authors:  M Hahne; T Kataoka; M Schröter; K Hofmann; M Irmler; J L Bodmer; P Schneider; T Bornand; N Holler; L E French; B Sordat; D Rimoldi; J Tschopp
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  75 in total

1.  Impaired IgA class switching in APRIL-deficient mice.

Authors:  Emanuela Castigli; Sumi Scott; Fatma Dedeoglu; Paul Bryce; Haifa Jabara; Atul K Bhan; Emiko Mizoguchi; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

2.  A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.

Authors:  Yulia Vugmeyster; Dhaya Seshasayee; Wesley Chang; Anahid Storn; Kathy Howell; Susan Sa; Tenea Nelson; Flavius Martin; Iqbal Grewal; Ellen Gilkerson; Ben Wu; Jeff Thompson; Barbara N Ehrenfels; Song Ren; An Song; Thomas R Gelzleichter; Dimitry M Danilenko
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  APRIL:TACI axis is dispensable for the immune response to rabies vaccination.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Andrew G Lytle; Kishore R Alugupalli; Joseph R Plummer; James P McGettigan
Journal:  Antiviral Res       Date:  2017-06-12       Impact factor: 5.970

Review 4.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

5.  Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.

Authors:  Zhong L Ju; Gui Y Shi; Jin X Zuo; Jing W Zhang
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

Review 6.  B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases.

Authors:  William Stohl
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

7.  CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.

Authors:  Julia Bluhm; Elisa Kieback; Stephen F Marino; Felix Oden; Jörg Westermann; Markus Chmielewski; Hinrich Abken; Wolfgang Uckert; Uta E Höpken; Armin Rehm
Journal:  Mol Ther       Date:  2018-06-18       Impact factor: 11.454

8.  BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.

Authors:  Jérôme Moreaux; Eric Legouffe; Eric Jourdan; Philippe Quittet; Thierry Rème; Cécile Lugagne; Philippe Moine; Jean-François Rossi; Bernard Klein; Karin Tarte
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

9.  BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

Authors:  Danielle T Avery; Susan L Kalled; Julia I Ellyard; Christine Ambrose; Sarah A Bixler; Marilyn Thien; Robert Brink; Fabienne Mackay; Philip D Hodgkin; Stuart G Tangye
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.